<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="191337-2018"
            EDITION="2018085">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-195457-001</RECEPTION_ID>
      <DELETION_DATE>20180809</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>85</NO_OJ>
         <DATE_PUB>20180503</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 085-191337</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:191337-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="UK"/>
         <IA_URL_GENERAL>http://www.nhsscotlandprocurement.scot.nhs.uk/</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="UKM">SCOTLAND</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="UKM">SCOTLAND</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="UK">UNITED KINGDOM</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="GBP">222830</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2018/S 028-060408</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180501</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Обединено кралство</TI_CY>
            <TI_TOWN>Единбург</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Spojené království/Velká Británie</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Forenede Kongerige, Det</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>das Vereinigte Königreich</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ηνωμένο Βασίλειο</TI_CY>
            <TI_TOWN>Εδιμβούργο</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>United Kingdom</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Suurbritannia / Ühendkuningriik</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Yhdistynyt kuningaskunta</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Royaume-Uni</TI_CY>
            <TI_TOWN>Édimbourg</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ríocht Aontaithe, an</TI_CY>
            <TI_TOWN>Dún Éideann</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Ujedinjena Kraljevina</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Egyesült Királyság</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Regno Unito</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY>
            <TI_TOWN>Edinburgas</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Apvienotā Karaliste</TI_CY>
            <TI_TOWN>Edinburga</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Ir-Renju Unit</TI_CY>
            <TI_TOWN>Edinbugh</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Verenigd Koninkrijk</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Zjednoczone Królestwo</TI_CY>
            <TI_TOWN>Edynburg</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Regatul Unit</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Spojené kráľovstvo</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Združeno kraljestvo</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Förenade kungariket</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>0dfcf740-1609-4c14-a428-edbfe63302d8</NOTICE_UUID>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="EN">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")</OFFICIALNAME>
               <ADDRESS>Gyle Square (NSS Head Office), 1 South Gyle Crescent</ADDRESS>
               <TOWN>Edinburgh</TOWN>
               <POSTAL_CODE>EH12 9EB</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <CONTACT_POINT>Hazel Johnstone</CONTACT_POINT>
               <PHONE>+44 1698794561</PHONE>
               <E_MAIL>hazel.johnstone@nhs.net</E_MAIL>
               <n2016:NUTS CODE="UKM"/>
               <URL_GENERAL>http://www.nhsscotlandprocurement.scot.nhs.uk/</URL_GENERAL>
               <URL_BUYER>http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CENTRAL_PURCHASING/>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Anagrelide, Ezetimibe, Ivabradine and Rosuvastatin</P>
            </TITLE>
            <REFERENCE_NUMBER>NP47518</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>This framework agreement is for the supply of Anagrelide, Ezetimibe, Ivabradine and Rosuvastatin tablets to health boards across NHS Scotland.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="GBP">222830</VAL_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <n2016:NUTS CODE="UKM"/>
               <MAIN_SITE>
                  <P>All entities constituted pursuant to the National health services (Scotland) Act 1978, and any Integrated joint boards established pursuant to New public bodies (Joint working) Scotland Act 2014.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>This framework is for the supply of Anagrelide, Ezetimibe, Ivabradine and Rosuvastatin tablets to health boards across NHS Scotland.</P>
                  <P>The Authority has awarded a single-supplier framework agreement on a line by line basis.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Logistics</AC_CRITERION>
                  <AC_WEIGHTING>5</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>95</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2018/S 028-060408</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>NP47518</CONTRACT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-04-04</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>11</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Generics [UK] t/a Mylan</OFFICIALNAME>
                     <ADDRESS>Albany Gate,, Darkes Lane</ADDRESS>
                     <TOWN>Potters Bar</TOWN>
                     <POSTAL_CODE>EN6 1AG</POSTAL_CODE>
                     <COUNTRY VALUE="UK"/>
                     <PHONE>+44 1707601269</PHONE>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Actavis UK Ltd</OFFICIALNAME>
                     <ADDRESS>Whiddon Valley</ADDRESS>
                     <TOWN>Barnstaple</TOWN>
                     <POSTAL_CODE>EX32 8NS</POSTAL_CODE>
                     <COUNTRY VALUE="UK"/>
                     <PHONE>+44 1271311398</PHONE>
                     <FAX>+44 1271311419</FAX>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glenmark Pharmaceuticals Europe Ltd</OFFICIALNAME>
                     <ADDRESS>Building 2, Croxley Green Business Park</ADDRESS>
                     <TOWN>Watford</TOWN>
                     <POSTAL_CODE>WD18 8YA</POSTAL_CODE>
                     <COUNTRY VALUE="UK"/>
                     <PHONE>+44 7502241635</PHONE>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="GBP">222830</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>The estimated value referred to in Section II.I.7 and V.2.4 covers the initial 15 months contract duration and the 2 x 12 month extension periods of the framework agreement.</P>
               <P>Further details of the lines awarded to each of the listed framework participants can be obtained using the contact details at the head of this notice.</P>
               <P>(SC Ref: 540694).</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")</OFFICIALNAME>
               <ADDRESS>Gyle Square (NSS Head Office), 1 South Gyle Crescent</ADDRESS>
               <TOWN>Edinburgh</TOWN>
               <POSTAL_CODE>EH12 9EB</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <PHONE>+44 1698794410</PHONE>
               <URL>http://www.nhsscotlandprocurement.scot.nhs.uk/</URL>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-05-01</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
